219 related articles for article (PubMed ID: 23250602)
21. A novel nonsense mutation in a Japanese family with ataxia with oculomotor apraxia type 2 (AOA2).
Nakamura K; Yoshida K; Makishita H; Kitamura E; Hashimoto S; Ikeda S
J Hum Genet; 2009 Dec; 54(12):746-8. PubMed ID: 19893583
[TBL] [Abstract][Full Text] [Related]
22. Ataxia with oculomotor apraxia type 1 (AOA1): clinical and neuropsychological features in 2 new patients and differential diagnosis.
D'Arrigo S; Riva D; Bulgheroni S; Chiapparini L; Castellotti B; Gellera C; Pantaleoni C
J Child Neurol; 2008 Aug; 23(8):895-900. PubMed ID: 18403580
[TBL] [Abstract][Full Text] [Related]
23. Identification and characterisation of a large senataxin (SETX) gene duplication in ataxia with ocular apraxia type 2 (AOA2).
Arning L; Schöls L; Cin H; Souquet M; Epplen JT; Timmann D
Neurogenetics; 2008 Oct; 9(4):295-9. PubMed ID: 18663494
[TBL] [Abstract][Full Text] [Related]
24. Exon deletions and intragenic insertions are not rare in ataxia with oculomotor apraxia 2.
Bernard V; Minnerop M; Bürk K; Kreuz F; Gillessen-Kaesbach G; Zühlke C
BMC Med Genet; 2009 Sep; 10():87. PubMed ID: 19744353
[TBL] [Abstract][Full Text] [Related]
25. Early-onset ataxia with oculomotor apraxia with a novel APTX mutation.
Ito A; Yamagata T; Mori M; Momoi MY
Pediatr Neurol; 2005 Jul; 33(1):53-6. PubMed ID: 15876520
[TBL] [Abstract][Full Text] [Related]
26. Comparing ataxias with oculomotor apraxia: a multimodal study of AOA1, AOA2 and AT focusing on video-oculography and alpha-fetoprotein.
Mariani LL; Rivaud-Péchoux S; Charles P; Ewenczyk C; Meneret A; Monga BB; Fleury MC; Hainque E; Maisonobe T; Degos B; Echaniz-Laguna A; Renaud M; Wirth T; Grabli D; Brice A; Vidailhet M; Stoppa-Lyonnet D; Dubois-d'Enghien C; Le Ber I; Koenig M; Roze E; Tranchant C; Durr A; Gaymard B; Anheim M
Sci Rep; 2017 Nov; 7(1):15284. PubMed ID: 29127364
[TBL] [Abstract][Full Text] [Related]
27. Ataxia with oculomotor apraxia type 2: a clinical, pathologic, and genetic study.
Criscuolo C; Chessa L; Di Giandomenico S; Mancini P; Saccà F; Grieco GS; Piane M; Barbieri F; De Michele G; Banfi S; Pierelli F; Rizzuto N; Santorelli FM; Gallosti L; Filla A; Casali C
Neurology; 2006 Apr; 66(8):1207-10. PubMed ID: 16636238
[TBL] [Abstract][Full Text] [Related]
28. Ataxia with oculomotor apraxia type 1 in Southern Italy: late onset and variable phenotype.
Criscuolo C; Mancini P; Saccà F; De Michele G; Monticelli A; Santoro L; Scarano V; Banfi S; Filla A
Neurology; 2004 Dec; 63(11):2173-5. PubMed ID: 15596775
[TBL] [Abstract][Full Text] [Related]
29. Unique Ataxia-Oculomotor Apraxia 2 (AOA2) in Israel with Novel Variants, Atypical Late Presentation, and Possible Identification of a Poison Exon.
Ponger P; Kurolap A; Lerer I; Dagan J; Chai Gadot C; Mory A; Wilnai Y; Oniashvili N; Giladi N; Gurevich T; Meiner V; Lossos A; Baris Feldman H
J Mol Neurosci; 2022 Aug; 72(8):1715-1723. PubMed ID: 35676594
[TBL] [Abstract][Full Text] [Related]
30. A novel mutation of aprataxin associated with ataxia ocular apraxia type 1: phenotypical and genotypical characterization.
Ferrarini M; Squintani G; Cavallaro T; Ferrari S; Rizzuto N; Fabrizi GM
J Neurol Sci; 2007 Sep; 260(1-2):219-24. PubMed ID: 17572444
[TBL] [Abstract][Full Text] [Related]
31. Identification of novel senataxin mutations in Chinese patients with autosomal recessive cerebellar ataxias by targeted next-generation sequencing.
Lu C; Zheng YC; Dong Y; Li HF
BMC Neurol; 2016 Sep; 16(1):179. PubMed ID: 27644330
[TBL] [Abstract][Full Text] [Related]
32. Structure of an aprataxin-DNA complex with insights into AOA1 neurodegenerative disease.
Tumbale P; Appel CD; Kraehenbuehl R; Robertson PD; Williams JS; Krahn J; Ahel I; Williams RS
Nat Struct Mol Biol; 2011 Oct; 18(11):1189-95. PubMed ID: 21984210
[TBL] [Abstract][Full Text] [Related]
33. Ataxia with oculomotor apraxia type 2: clinical, biological and genotype/phenotype correlation study of a cohort of 90 patients.
Anheim M; Monga B; Fleury M; Charles P; Barbot C; Salih M; Delaunoy JP; Fritsch M; Arning L; Synofzik M; Schöls L; Sequeiros J; Goizet C; Marelli C; Le Ber I; Koht J; Gazulla J; De Bleecker J; Mukhtar M; Drouot N; Ali-Pacha L; Benhassine T; Chbicheb M; M'Zahem A; Hamri A; Chabrol B; Pouget J; Murphy R; Watanabe M; Coutinho P; Tazir M; Durr A; Brice A; Tranchant C; Koenig M
Brain; 2009 Oct; 132(Pt 10):2688-98. PubMed ID: 19696032
[TBL] [Abstract][Full Text] [Related]
34. Ataxia with oculomotor apraxia type1 (AOA1): novel and recurrent aprataxin mutations, coenzyme Q10 analyses, and clinical findings in Italian patients.
Castellotti B; Mariotti C; Rimoldi M; Fancellu R; Plumari M; Caimi S; Uziel G; Nardocci N; Moroni I; Zorzi G; Pareyson D; Di Bella D; Di Donato S; Taroni F; Gellera C
Neurogenetics; 2011 Aug; 12(3):193-201. PubMed ID: 21465257
[TBL] [Abstract][Full Text] [Related]
35. Novel SETX variants in a patient with ataxia, neuropathy, and oculomotor apraxia are associated with normal sensitivity to oxidative DNA damaging agents.
Vantaggiato C; Cantoni O; Guidarelli A; Romaniello R; Citterio A; Arrigoni F; Doneda C; Castelli M; Airoldi G; Bresolin N; Borgatti R; Bassi MT
Brain Dev; 2014 Sep; 36(8):682-9. PubMed ID: 24183476
[TBL] [Abstract][Full Text] [Related]
36. Early-onset ataxia with ocular motor apraxia and hypoalbuminemia: the aprataxin gene mutations.
Shimazaki H; Takiyama Y; Sakoe K; Ikeguchi K; Niijima K; Kaneko J; Namekawa M; Ogawa T; Date H; Tsuji S; Nakano I; Nishizawa M
Neurology; 2002 Aug; 59(4):590-5. PubMed ID: 12196655
[TBL] [Abstract][Full Text] [Related]
37. Familial cognitive impairment with ataxia with oculomotor apraxia.
Mahajnah M; Basel-Vanagaite L; Inbar D; Kornreich L; Weitz R; Straussberg R
J Child Neurol; 2005 Jun; 20(6):523-5. PubMed ID: 15996403
[TBL] [Abstract][Full Text] [Related]
38. [Ataxia with oculomotor apraxia type 4 detected by next-generation sequencing].
Rudenskaya GE; Surkova EI; Konovalov FA
Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(3):10-14. PubMed ID: 29652299
[TBL] [Abstract][Full Text] [Related]
39. Autosomal recessive cerebellar ataxia with oculomotor apraxia (ataxia-telangiectasia-like syndrome) is linked to chromosome 9q34.
Németh AH; Bochukova E; Dunne E; Huson SM; Elston J; Hannan MA; Jackson M; Chapman CJ; Taylor AM
Am J Hum Genet; 2000 Nov; 67(5):1320-6. PubMed ID: 11022012
[TBL] [Abstract][Full Text] [Related]
40. A novel nonsense mutation in the APTX gene associated with delayed DNA single-strand break removal fails to enhance sensitivity to different genotoxic agents.
Crimella C; Cantoni O; Guidarelli A; Vantaggiato C; Martinuzzi A; Fiorani M; Azzolini C; Orso G; Bresolin N; Bassi MT
Hum Mutat; 2011 Apr; 32(4):E2118-33. PubMed ID: 21412945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
